Overview
Parkinson's disease is a chronic, progressive disorder of the nervous system that mainly impairs movement and a range of non-motor functions. It arises when specific nerve cells in the brain decline or die, reducing the supply of chemical messengers needed for coordinated motion and other processes. The condition is most often diagnosed in middle-aged and older adults but can appear earlier. While there is no cure, many treatments can reduce symptoms and improve quality of life.
Anatomy and basic mechanism
Parkinson's affects the central nervous system, which includes both the brain and the spinal cord. In Parkinson's disease, a population of neurons that produce dopamine in a brain region called the substantia nigra becomes depleted. The loss of these cells reduces dopaminergic signals to areas that control movement and balance, disrupting normal motor function and coordination. Microscopic protein aggregates known as Lewy bodies—rich in the protein alpha-synuclein—are a characteristic pathological feature.
Common signs and symptoms
Symptoms vary between people and typically progress slowly. Motor signs are often most noticeable:
- Resting tremor: a rhythmic shaking, often starting in a hand or fingers.
- Bradykinesia: slowness of movement and reduced automatic motions.
- Rigidity: stiffness of the limbs and trunk.
- Postural instability: impaired balance and increased fall risk in later stages.
Non-motor symptoms are also common and can precede motor signs: reduced sense of smell, constipation, sleep disturbances, mood changes (depression, anxiety), autonomic dysfunction, and cognitive decline in advanced disease.
Causes, risk factors and development
The exact cause is not fully understood. Most cases are considered idiopathic, with a complex interplay of age-related vulnerability, genetic predisposition, and environmental exposures. Certain genes have been linked to familial forms of Parkinson's, and research has identified environmental factors that may increase risk. The disease course and severity vary widely among individuals.
Diagnosis and investigations
Diagnosis is primarily clinical, based on medical history and examination for cardinal motor signs. No single laboratory test confirms Parkinson's disease, but neuroimaging and specialized scans can help exclude other conditions or support the clinical impression. Referral to a neurologist with movement-disorder expertise is common for uncertain or early cases. For further background on the condition as a whole, see the general entry on Parkinson's disease.
Treatment and management
Treatment aims to reduce symptoms and maintain function. Medications that restore or mimic dopamine activity, most notably levodopa, are the most effective for motor symptoms. Other drug classes include dopamine agonists and MAO-B inhibitors. Non-pharmacological therapies—physiotherapy, occupational therapy, speech and swallowing therapy—are important for mobility and daily living. In selected cases, surgical options such as deep brain stimulation can provide substantial benefit for motor fluctuations and dyskinesia.
Prognosis, importance and current research
Parkinson's disease progresses at different rates. Many people live for years with good symptom control, though later stages increase the risk of complications that can affect life expectancy and independence. Research continues into causes, biomarkers for earlier diagnosis, disease-modifying therapies, and improved symptomatic treatments. Clinical and laboratory advances aim to better understand how loss of dopaminergic neurons in the nervous system and related protein abnormalities lead to the diverse features of the disorder.
Distinctions and notable facts
- Parkinsonism is a term for the movement disorder syndrome that includes Parkinson's disease and other conditions with similar motor features; not all parkinsonism is due to idiopathic Parkinson's.
- Early non-motor signs such as loss of smell or constipation may appear years before motor symptoms, offering a potential window for earlier recognition and research into prevention.
- Comprehensive care often involves a multidisciplinary team: neurologists, therapists, nurses and social support to address motor and non-motor aspects of the disease.
For clinical summaries and patient resources on treatments, diagnosis and ongoing studies, consult specialized neurology sources and patient organizations. See also information on the motor system and how it is affected by dopamine changes, as well as general neuroscience entries on the brain and spinal cord for context. Additional medical background can be found through reference materials at dopamine-focused resources and overviews of neural cell biology at cell-level discussions.
